DMKPQ (DMK Pharmaceuticals) Insider Ownership: 85.01 % (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DMKPQ DMK Pharmaceuticals Corp DMKPQ
16 GF Score
Price $0.00
View Full Analysis

What is DMK Pharmaceuticals Insider Ownership?

DMK Pharmaceuticals DMKPQ -99.00% 16 Insider Ownership is 85.01 % as of Aug. 12, 2026. GuruFocus rates DMKPQ with a GF Score™ of 16/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DMK Pharmaceuticals's insider ownership is 85.01%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DMK Pharmaceuticals's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DMK Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 90.91%.

DMK Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for DMK Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DMK Pharmaceuticals Insider Ownership Chart

DMK Pharmaceuticals Historical Data

The historical data trend for DMK Pharmaceuticals can be seen below:

2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31
Insider Ownership 85.01 85.01 85.01 85.01 85.01 85.01 85.01 85.01 85.01 85.01
DMKPQ
16GF Score
DMK Pharmaceuticals Corp DMKPQ
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DMK Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 85.01 % mean?
DMK Pharmaceuticals (DMKPQ) has a Insider Ownership of 85.01 % as of Aug. 12, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on DMK Pharmaceuticals and its competitors.
Is DMK Pharmaceuticals' Insider Ownership too high?
DMK Pharmaceuticals' current Insider Ownership is 85.01 %. Overall, DMK Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does DMK Pharmaceuticals' Insider Ownership compare to CNNC and THCT?
DMK Pharmaceuticals' Insider Ownership of 85.01 % can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Drug Manufacturers company?
A good Insider Ownership depends on the Drug Manufacturers industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on DMK Pharmaceuticals and its competitors. DMK Pharmaceuticals's current Insider Ownership is 85.01 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DMK Pharmaceuticals stock overvalued right now?
DMK Pharmaceuticals (DMKPQ) has a current Insider Ownership of 85.01 %. The current Insider Ownership is 85.01 %. DMK Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For DMK Pharmaceuticals (DMKPQ), the current Insider Ownership is 85.01 % as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DMK Pharmaceuticals Business Description

Address 11682 El Camino Real, Suite 300, San Diego, CA, USA, 92130
DMK Pharmaceuticals Corp Formerly Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
16GF Score

Get the complete analysis for DMKPQ

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price